Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study

BACKGROUND: Prior studies suggested that vancomycin may be inferior to β-lactams for the empiric treatment of methicillin-susceptible S. aureus (MSSA) bacteremia. We assessed whether empiric therapy with β-lactams compared to vancomycin was associated with differences in clinical outcomes in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Davie, Wong, Titus, Romney, Marc, Leung, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878066/
https://www.ncbi.nlm.nih.gov/pubmed/27215201
http://dx.doi.org/10.1186/s12879-016-1564-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878066/
https://www.ncbi.nlm.nih.gov/pubmed/27215201
http://dx.doi.org/10.1186/s12879-016-1564-5

Ejemplares similares